Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah J Scotland

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Frontiers in Bioscience (Landmark Edition)|November 5, 2016
The Bad, the Good and eIF3e/INT6Julie Sesen, Joshua Casaos, Sarah J Scotland, et al.
International Journal of Molecular Sciences|February 1, 2014
Int6/eIF3e is essential for proliferation and survival of human glioblastoma cellsJulie Sesen, Anne Cammas, Sarah J Scotland, et al.
Plos One|April 14, 2015
Metformin inhibits growth of human glioblastoma cells and enhances therapeutic responseJulie Sesen, Perrine Dahan, Sarah J Scotland, et al.
Oncotarget|March 1, 2018
Ribavirin as a potential therapeutic for atypical teratoid/rhabdoid tumorsJoshua Casaos, Sakibul Huq, Tarik Lott, et al.
Pediatric Research|September 1, 2023
Outcomes up to age 36 months after congenital Zika virus infection-U.S. statesVarsha Neelam, Kate R Woodworth, Daniel J Chang, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Frontiers in Bioscience (Landmark Edition)|November 5, 2016
The Bad, the Good and eIF3e/INT6Julie Sesen, Joshua Casaos, Sarah J Scotland, et al.
International Journal of Molecular Sciences|February 1, 2014
Int6/eIF3e is essential for proliferation and survival of human glioblastoma cellsJulie Sesen, Anne Cammas, Sarah J Scotland, et al.
Plos One|April 14, 2015
Metformin inhibits growth of human glioblastoma cells and enhances therapeutic responseJulie Sesen, Perrine Dahan, Sarah J Scotland, et al.
Oncotarget|March 1, 2018
Ribavirin as a potential therapeutic for atypical teratoid/rhabdoid tumorsJoshua Casaos, Sakibul Huq, Tarik Lott, et al.
Pediatric Research|September 1, 2023
Outcomes up to age 36 months after congenital Zika virus infection-U.S. statesVarsha Neelam, Kate R Woodworth, Daniel J Chang, et al.
Pageof 1